Antiparkinsonian-like effects of CPL500036, a novel selective inhibitor of phosphodiesterase 10A, in the unilateral rat model of Parkinson's disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antiparkinsonian-like effects of CPL500036, a novel selective inhibitor of phosphodiesterase 10A, in the unilateral rat model of Parkinson's disease

Published:2021-11 Issue: Volume:910 Page:174460
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Lenda Tomasz^ORCID,Ossowska Krystyna,Berghauzen-Maciejewska Klemencja,Matłoka Mikołaj,Pieczykolan Jerzy,Wieczorek Maciej,Konieczny Jolanta^ORCID

Publisher

Elsevier BV

Subject

Pharmacology

Reference51 articles.

1. Repetitive vibrissae-elicited forelimb placing before and immediately after unilateral 6-hydroxydopamine improves outcome in a model of Parkinson's disease;Anstrom;Behav. Brain Res.,2007

2. Ameliorative effects of a phosphodiesterase 10A inhibitor, MR1916 on L-DOPA-induced dyskinesia in parkinsonian rats;Arakawa;Pharmacol. Rep.,2020

3. A selective phosphodiesterase 10A inhibitor reduces l-dopa-induced dyskinesias in parkinsonian monkeys;Beck;Mov. Disord.,2018

4. Neurotoxin-based models of Parkinson's disease;Bové;Neuroscience,2012

5. Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment;Carta;Eur. J. Neurosci.,2005

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson’s disease;GeroScience;2024-04-02

2. Emerging phosphodiesterase inhibitors for treatment of neurodegenerative diseases;Medicinal Research Reviews;2024-01-27

3. Targeting Striatal Glutamate and Phosphodiesterases to Control L-DOPA-Induced Dyskinesia;Cells;2023-11-30

4. Single-nucleus transcriptomics reveals disease- and pathology-specific signatures in α-synucleinopathies;2023-10-10

5. The Potential of Cylindromatosis (CYLD) as a Therapeutic Target in Oxidative Stress-Associated Pathologies: A Comprehensive Evaluation;International Journal of Molecular Sciences;2023-05-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3